Riverbridge Partners Lowers stake in Chemed Corporation (CHE)

Chemed Corporation (CHE) : Riverbridge Partners reduced its stake in Chemed Corporation by 3.02% during the most recent quarter end. The investment management company now holds a total of 822,643 shares of Chemed Corporation which is valued at $119,316,141 after selling 25,659 shares in Chemed Corporation , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Chemed Corporation makes up approximately 2.40% of Riverbridge Partners’s portfolio.

Other Hedge Funds, Including , New Amsterdam Partnersny added CHE to its portfolio by purchasing 20,828 company shares during the most recent quarter which is valued at $3,020,893. Chemed Corporation makes up approx 0.70% of New Amsterdam Partnersny’s portfolio.Smith Salley Associates boosted its stake in CHE in the latest quarter, The investment management firm added 60 additional shares and now holds a total of 1,815 shares of Chemed Corporation which is valued at $267,059. Chemed Corporation makes up approx 0.06% of Smith Salley Associates’s portfolio.Palo Capital boosted its stake in CHE in the latest quarter, The investment management firm added 8,900 additional shares and now holds a total of 16,880 shares of Chemed Corporation which is valued at $2,411,308. Chemed Corporation makes up approx 0.80% of Palo Capital’s portfolio.

Chemed Corporation closed down -1.29 points or -0.89% at $143.75 with 51,910 shares getting traded on Thursday. Post opening the session at $144.7, the shares hit an intraday low of $143.56 and an intraday high of $146.64 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Chemed Corporation reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.72. The company had revenue of $390.40 million for the quarter, compared to analysts expectations of $393.76 million. The company’s revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS.

Many Wall Street Analysts have commented on Chemed Corporation. Company shares were Reiterated by RBC Capital Mkts on Jul 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 162 from a previous price target of $136 .

Chemed Corporation (Chemed) purchases operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians registered nurses home health aides social workers clergy and volunteers. VITAS and Innovative Hospice Care are trademarks and service marks of VITAS Healthcare Corporation a wholly owned indirect subsidiary of the Company. The Company’s Roto-Rooter segment provides plumbing and drain cleaning services to both residential and commercial customers. The Roto-Rootera trademarks and service marks are used and advertised by Roto-Rooter Corporation a wholly owned indirect subsidiary of the Company. The Company operates through two wholly owned subsidiaries: VITAS Healthcare Corporation and Roto-Rooter Group Inc.

Leave a Reply

Chemed Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemed Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.